This paper responds to the “Questions for Public Comment” (“QFPCs”) posed by the FTC and DOJ (“Agencies”) on September 22, 2009.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...

